GlassScriptPhysician profile
Krithika Krishnarao
NPI 1366886814
$3,552.31
in general payments reported to CMS, 2019-2025
12 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $102 · 2021: $216 · 2022: $317 · 2023: $2,412 · 2024: $26.67 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,706 · Food and Beverage: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,706.29 |
| Food and Beverage | $985.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,876.66 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $1,116.89 | 2022-2025 | Impella |
| Stratus Medical, LLC | $163.31 | 2025 | Nimbus |
| Astrazeneca Pharmaceuticals LP | $116.14 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $99.00 | 2022 | |
| Amgen INC. | $63.44 | 2019-2023 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $23.82 | 2022 | |
| United Therapeutics Corporation | $21.32 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.77 | 2023-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $18.70 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.70 | 2023 | |
| Pfizer INC. | $16.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krithika Krishnarao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.